OpenLegislation

Paragraph 2 Marketing authorizations

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Notwithstanding the provisions of paragraph 1, in the case of an article or substance to which Part II of the Act applies by virtue of the Medicines (Surgical Materials) Order 1971f1, the fees payable under regulation 14(3) in connection with the holding of a marketing authorization or licence shall, where appropriate, be—

(a)

a standard fee of £300;

(b)

a reduced rate fee of £145; or

(c)

a maintenance fee of £95.

Annotations

Footnotes

f1

S.I.1971/1267.